Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/3/2025 | $5.00 | Buy | Canaccord Genuity |
12/9/2024 | $4.50 | Overweight | KeyBanc Capital Markets |
12/4/2024 | $5.00 | Outperform | Mizuho |
11/20/2024 | $5.00 | Outperform | Northland Capital |
7/1/2024 | Hold | Needham | |
1/3/2024 | $2.50 | Equal Weight | Barclays |
12/2/2021 | $2.00 | Hold | Jefferies |
11/16/2021 | $10.00 → $3.00 | Outperform → Neutral | Robert W. Baird |
Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00
KeyBanc Capital Markets initiated coverage of Talkspace with a rating of Overweight and set a new price target of $4.50
Mizuho initiated coverage of Talkspace with a rating of Outperform and set a new price target of $5.00
8-K - Talkspace, Inc. (0001803901) (Filer)
SCHEDULE 13G/A - Talkspace, Inc. (0001803901) (Subject)
10-Q - Talkspace, Inc. (0001803901) (Filer)
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the following upcoming investor conferences: The Truist Healthcare Disruptors & Digital Health Conference, being held in New York, including 1x1 meetings with investors on Tuesday, June 24, 2025, and a panel discussion on "Addressing the Mental Health Crisis" with Chief Executive Officer, Dr. Jon Cohen, on Wednesday, June 25, 2025 at 2:40pm ET.The Northland Growth Conference, being held virtually, including 1x1 meetings with investors on Wednesday, June 25, 2025. About Talkspace Talkspace (NASDAQ:TALK) is a le
Amazon Pharmacy now streamlines medication fulfillment for Talkspace members. Talkspace (NASDAQ:TALK), a leading online behavioral health company, today announced a new collaboration with Amazon Pharmacy to simplify the pharmacy experience for Talkspace members and streamline medication management and adherence support for providers. Mental health medication adherence remains a significant challenge in the U.S., with adherence rates ranging between 45% and 55% for many common conditions. Cost and access are two of the most persistent barriers. A study published in JAMA Psychiatry found that 21% of individuals with depression did not fill a prescribed medication in the past year due to c
WEST DES MOINES, Iowa, May 7, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced strategic partnerships with Talkspace (NASDAQ:TALK), movr, and Springbuk, adding significant strength to its partner ecosystem. These leading solutions address three of the most urgent and costly areas in workforce health: mental health, musculoskeletal (MSK) care, and population health intelligence. "Employers are no longer willing to take a trial-and-error approach to employee health benefits," stated Troy Vincent, Founder and CEO of Navigate Wellbeing Solutions. "Our wellbeing solution